|
|
|
Insider
Information: |
Parschauer Karah Herdman |
Relationship: |
Director |
City: |
Novato |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
105,047 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$3,190,579 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
105,047 |
|
|
Total
Value |
$3,190,579 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
12
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
0
|
10
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-109.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Ultragenyx Pharmaceutical Inc |
RARE |
|
2024-03-01 |
67,340 |
2016-06-20 |
0 |
Premium* |
|
Evolus Inc |
EOLS |
Director |
2024-02-07 |
37,707 |
2021-02-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
62 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
EOLS |
Evolus Inc |
Director |
|
2021-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
19,313 |
19,313 |
0 |
- |
|
EOLS |
Evolus Inc |
Director |
|
2022-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
15,568 |
34,881 |
0 |
- |
|
EOLS |
Evolus Inc |
Director |
|
2023-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
8,293 |
43,174 |
0 |
- |
|
EOLS |
Evolus Inc |
Director |
|
2024-01-30 |
4 |
S |
$13.14 |
$156,733 |
D/D |
(11,931) |
31,243 |
0 |
% |
|
EOLS |
Evolus Inc |
Director |
|
2024-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
6,464 |
37,707 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Legal Officer |
|
2022-03-01 |
4 |
S |
$66.62 |
$192,265 |
D/D |
(2,886) |
25,472 |
0 |
% |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Legal Officer |
|
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
14,000 |
39,578 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Legal Officer |
|
2022-03-07 |
4 |
S |
$62.95 |
$323,563 |
D/D |
(5,140) |
34,438 |
0 |
% |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Legal Officer |
|
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
24,663 |
59,101 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Legal Officer |
|
2023-03-01 |
4 |
S |
$45.25 |
$143,035 |
D/D |
(3,161) |
56,139 |
0 |
% |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Legal Officer |
|
2023-05-04 |
4 |
AS |
$45.00 |
$197,010 |
D/D |
(4,378) |
51,982 |
0 |
% |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Legal Officer |
|
2024-03-01 |
4 |
S |
$53.76 |
$201,923 |
D/D |
(3,756) |
67,340 |
0 |
% |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Legal Officer |
|
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
18,757 |
70,739 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
|
2016-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
7,500 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
|
2017-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
9,500 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
|
2017-06-20 |
4 |
D |
$63.38 |
$44,683 |
D/D |
(705) |
8,795 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
|
2018-03-01 |
4 |
D |
$48.43 |
$9,928 |
D/D |
(205) |
16,090 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
|
2018-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
16,295 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
|
2018-04-19 |
4 |
A |
$0.00 |
$0 |
D/D |
1,431 |
17,521 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
|
2018-05-10 |
4 |
AS |
$60.00 |
$87,900 |
D/D |
(1,465) |
16,056 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
|
2018-06-20 |
4 |
D |
$85.31 |
$55,366 |
D/D |
(649) |
15,407 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
|
2018-06-21 |
4 |
AS |
$82.77 |
$101,476 |
D/D |
(1,226) |
14,181 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
|
2018-08-21 |
4 |
S |
$78.53 |
$392,650 |
D/D |
(5,000) |
9,181 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
|
2018-08-21 |
4/A |
OE |
$54.50 |
$272,500 |
D/D |
5,000 |
19,181 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
|
2018-08-21 |
4/A |
S |
$78.53 |
$392,650 |
D/D |
(5,000) |
14,181 |
0 |
- |
|
62 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|